A Trial to Study the Influence of Growth Factors on Bone Marrow and Hepatic Regeneration in Patients With Decompensated Cirrhosis.
Launched by INSTITUTE OF LIVER AND BILIARY SCIENCES, INDIA · Jul 17, 2013
Trial Information
Current as of June 18, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects aged 18-65 years
- • All patients who are known to have cirrhosis of liver with portal hypertension and are compensated on presentation with no features of ascites/ jaundice/ bleed/ HE/ HRS.
- • Only patients with alcoholic cirrhosis and cryptogenic cirrhosis (etiology work up negative) will be enrolled in the study.
- Exclusion Criteria:
- • Sepsis ( Any culture positive: blood, urine, any other obvious source of infection: UTI, LRTI)
- • Variceal bleed in the past 3 months
- • Autoimmune disorders
- • HCC (Hepatocellular Carcinoma)
- • Multi organ failure
- • Any features of decompensation in form of ascites/Jaundice/ HE (grade 3 or 4) / HRS
- • HIV seropositivity
- • Essential hypertension
- • Pregnancy
- • Refusal to participate in the study
About Institute Of Liver And Biliary Sciences, India
The Institute of Liver and Biliary Sciences (ILBS) in India is a premier research and healthcare institution dedicated to the advancement of knowledge and treatment in liver, biliary, and related diseases. As a clinical trial sponsor, ILBS is committed to conducting innovative and ethically-driven research to improve patient outcomes and enhance therapeutic options in hepatology. The institute fosters collaboration among multidisciplinary teams of clinicians, researchers, and healthcare professionals, ensuring rigorous scientific methodologies and adherence to regulatory standards. Through its focus on translational research, ILBS aims to bridge the gap between laboratory discoveries and clinical applications, ultimately contributing to the global understanding and management of liver diseases.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Delhi, Delhi, India
Patients applied
Trial Officials
Dr Lovkesh Anand, MD
Principal Investigator
Institute of Liver & Biliary Sciences.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials